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INTRODUCTION
ARTHUR C. CURTIS, M.D., Program Chairman*
This distinguished group of scientists, as-
sembled here today in the beautiful surroundings
of Brook Lodge, represent different and diverse
disciplines; and all have come for the purpose of
discussing, debating, and adding to our knowledge
of melanin pigmentation. This symposium will
not be limited to melanin pigmentation alone,
but will cover the field of radiation physics, the
chemical make-up of some compounds affecting
pigment, hormona] factors causing increased or
decreased pigmentation, and the clinical uses of
chemical, hormonal and physical agents in human
subjects. Through the kindness of The Upjohn
Company, its President, Dr. E. Gifford Upjohn,
its Medical Director, Dr. E. L. Burbidge, and
Dr. Harold A. Tucker of its department of clinical
investigation, this meeting has been made pos-
sible.
I have been asked to act as chairman of this
meeting. Undoubtedly this means no more than
the fact that I had the good fortune several years
ago to have as my associates Dr. Aaron B. Lerner,
now of Yale University, and Dr. Thomas B. Fitz-
patrick, now at the University of Oregon, both of
whose basic and clinical work in the field of
melanin pigmentation has been outstanding, and
both of whom are here with several of their staff.
My own contribution to this symposium will be
little, but I hope to learn much.
In modern systems of chemical nomenclature,
there is still disagreement as to the proper chem-
ical naming and numbering for the furocoumarin
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compounds. Using the best known of these,
"mcthoxsalcn", as an example, there arc three
possibilities, each designating a different numeri-
cal position for the mcthoxy radical. Chemical
Abstracts uses two names: (a) 9-mcthoxy-7H-
furo (3, 2-g) (1) bcnzopyran-7-onc and (b) 3-
lactonc of 6-hydroxy-7-methoxy-5-bcnzofurana-
crylic acid. The A.M.A. Council on Drugs like-
wise uses two systems with different numbering
systems: (c) 3-lactonc of 3-(6-hydroxy-7-mcth-
oxybenzofuranyl) acrylic acid and (d) S-methoxy-
psoralen.
In an effort to bring order to this situation,
experts on chemical nomenclature at The Upjohn
Company Research Laboratories and the Food
and Drug Administration in Washington, D. C.
reviewed chemical and clinical literature on the
furocoumarins and have made the following
recommendations: Formula (b), or (c) would
enable competent chemists to construct a correct
structural formula. In terms of established usage,
(d) would be more meaningful to most biological
and medical people. (The Council monograph in
N.N.R. has recognized this difference, as shown
by its approval and acceptance of two systems.)
It was suggested that the third system be used
("formula" d) for this publication, together with
the Council-accepted generic name "mcthox-
salcn". The following numerical designations
would apply:
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Total Spectrum of Radiant Energy
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THE COMPARATIVE NARROWNESS OF THE SOLAR SPECTRUM
WITHIN THE RANGE OF ALL KNOWN FORMS OF ELECTRO-
MAGNETIC RADIATION IS ILLUSTRATED IN THE FIGURE BELOW
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